About ReachBio Research Labs
ReachBio Research Labs is a Healthcare company based in Seattle (United States) founded in 2007, and was acquired by Discovery Life Sciences in April 2023. CRO focused on hematotoxicity assays and primary cells. The company has 10 employees. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In Vitro Assays. Its legal entity is REACHBIO LLC. Its competitors include Anabios, Quiver Bioscience and Zen-Bio; 1 of its 3 listed competitors has raised funding.
Company details
ReachBio Research Labs is a contract research organization specializing in hematotoxicity assays and primary cells. The companys focus is clinical, industrial and research use of primary cell biology especially the use of stem cell and progenitor cell assays and model systems for high-value applications such as drug screening and drug discovery. It offers a variety of human primary cells from peripheral blood, cord blood and bone marrow, including MNCs and purified stemprogenitor cells, lymphocyte subpopulations, optimized ColonyGEL formulations for evaluating hematopoietic progenitors from a variety of species including human, mouse, rat, canine and NHP. and Mesenchymal cells Media.
- Headquarters Seattle, United States
- Employees 10
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website reachbio.com
- Social LinkedIn X Facebook
- Acquired by Discovery Life Sciences (Apr 2023)
- Legal Name Reachbio Llc
- Investors
- Employee Count10
- Acquired byDiscovery Life Sciences
(Apr 2023)
Investors in ReachBio Research Labs
ReachBio Research Labs has secured backing from 1 investor. Prominent investors backing the company include Discovery Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of diversified services with integrated technology platforms for drug discovery | 2006 | dls.com | Huntsville, United States |
Investor details for ReachBio Research Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ReachBio Research Labs
4 people are tracked at ReachBio Research Labs (1 in leadership, 3 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Rob Chaney | COO, Co-Founder & General Manager | Leadership |
Kristen Perrino | Office Manager | Team |
Heather E. | Marketing Manager | Team |
Shanie R. | Administrative Coordinator | Team |
Complete people profiles for ReachBio Research Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ReachBio Research Labs
2 dated milestones of ReachBio Research Labs across 16 years, from founding to its latest funding, stage changes and deals.
- Founded ReachBio Research Labs is founded.
- Exit Acquired by Discovery Life Sciences.
Competitors of ReachBio Research Labs
ReachBio Research Labs has 3 listed competitors in our database, 1 of them funded. They include Anabios, Quiver Bioscience and Zen-Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anabios.com | 2009 | San Diego, United States | $24.78M | 51 | Ex-vivo human tissue studies are performed for preclinical drug discovery. | |
| quiverbioscience.com | 2013 | Cambridge, United States | Developer of transformational medicines for neurological disorders | |||
| zen-bio.com | 1995 | Durham, United States | Cell-based solutions are provided to accelerate therapy discovery and development. |
Detailed competitors of ReachBio Research Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ReachBio Research Labs
Websites that share an audience with ReachBio Research Labs (reachbio.com).
Websites whose visitors overlap most with ReachBio Research Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| marinbio.com | 100% | 4.9K | #4,360,368 | View details | |
 stemcellcollege.wordpress.com | stemcellcollege.wordpress.com | 63% | – | ||
| flucamp.com | 63% | #490,754 | View details | ||
| nbmtlink.org | 62% | #3,364,280 | View details | ||
bonemarrow.org | bonemarrow.org | 62% | #4,080,672 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ReachBio Research Labs (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reachbio Research Labs
Complete news archive for ReachBio Research Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ReachBio Research Labs
ReachBio Research Labs was founded in 2007.
ReachBio Research Labs is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
ReachBio Research Labs has 10 employees.
ReachBio Research Labs is a contract research organization specializing in hematotoxicity assays and primary cells. The companys focus is clinical, industrial and research use of primary cell biology especially the use of stem cell and progenitor cell assays and model systems for high-value applications such as drug screening and drug discovery. It offers a variety of human primary cells from peripheral blood, cord blood and bone marrow, including MNCs and purified stemprogenitor cells, lymphocyte subpopulations, optimized ColonyGEL formulations for evaluating hematopoietic progenitors from a variety of species including human, mouse, rat, canine and NHP. and Mesenchymal cells Media.
ReachBio Research Labs's top competitors include Quiver Bioscience, Anabios and Zen-Bio.
ReachBio Research Labs has 1 investor. Key investors include Discovery Life Sciences.
ReachBio Research Labs operates through Reachbio Llc.
Yes. ReachBio Research Labs was acquired by Discovery Life Sciences in April 2023.